MA
Muthukumar Amirthalingam
About Muthukumar Amirthalingam
Data last updated:
Muthukumar Amirthalingam is a Director at Newrish Pharmaceuticals Private Limited (since 2022). The company operates in Pharma. Newrish Pharmaceuticals Private Limited reported revenue of ₹1.69 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Newrish Pharmaceuticals Private Limited U24299TZ2022PTC038005 | Director | 19 Jan 2022 | 2022 | ₹1.69 Cr (FY 2025) | Active |
Board colleagues of Muthukumar Amirthalingam
| Name | DIN | Company | Designation |
|---|---|---|---|
| Seethalakshmi | 09472484 | Newrish Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muthukumar Amirthalingam
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muthukumar Amirthalingam
Muthukumar Amirthalingam currently holds 1 directorship: Newrish Pharmaceuticals Private Limited (Director, since 19 Jan 2022, revenue ₹1.69 Cr (FY 2025)).
Muthukumar Amirthalingam was first appointed on 19 Jan 2022 as Director at Newrish Pharmaceuticals Private Limited.
The current boards of Muthukumar Amirthalingam's companies include Seethalakshmi (Newrish Pharmaceuticals Private Limited).